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Precise patterning of axon guidance cue distribution
is critical for nervous system development. Using
a murine forward genetic screen for novel determi-
nants of axon guidance, we identified B3gnt1 and
ISPD as required for the glycosylation of dystrogly-
can in vivo. Analysis of B3gnt1, ISPD, and dys-
troglycan mutant mice revealed a critical role for
glycosylated dystroglycan in the development of
several longitudinal axon tracts. Remarkably, the
axonal guidance defects observed in B3gnt1, ISPD,
and dystroglycan mutants resemble several of the
axon guidance defects found in mice lacking the
axon guidance cue Slit and its receptor Robo. This
similarity is explained by our observations that dys-
troglycan binds directly to Slit and is required for
proper Slit localization within the basement mem-
brane and floor plate in vivo. These findings establish
a novel role for glycosylated dystroglycan as a key
determinant of axon guidance cue distribution and
function in the mammalian nervous system.
INTRODUCTION
Precise temporal and spatial expression patterns of extrinsic
instructive cues in the embryonic nervous system establish the
fidelity of developmental processes, including morphogenesis,
neuronal differentiation, polarization, axon guidance, and synap-
togenesis. Axon guidance is particularly reliant on proper cue
presentation because axons must often navigate long distances
in discrete sequential steps, with intermediate targets providing
precisely positioned instructional cues that orient axons toward
their next guidepost en route to final target fields (Garel and
Rubenstein, 2004). Recently, axon guidance defects have been
implicated in several human neurological disorders, although
the molecular etiology underlying these defects is poorly
understood (Engle, 2010).
Axon guidance cues can function as attractants or repellants
by binding to cell surface receptors that transduce guidance
information through signaling cascades that reorganize the actincytoskeleton within growth cones (Vitriol and Zheng, 2012).
These cues, which include members of the Slit, Netrin,
Semaphorin, and Ephrin families of ligands, are expressed in
or around intermediate and final target fields, or on neurons
themselves, whereas their respective receptors are expressed
on axonal growth cones (Kolodkin and Tessier-Lavigne, 2011).
Several axon guidance cues, such as Class 4-7 Semaphorins
and Ephrins, are either transmembrane or tethered to the plasma
membrane of the expressing cell through a GPI-linkage and
therefore function primarily as short-range cues. In contrast,
Slits, Netrins, Neurotrophins, and Class 3 Semaphorins, as well
as morphogens of the Wnt, Hedgehog, and TGFb families, are
secreted cues and may regulate axonal growth and guidance
at both long and short range.
Extending axons encounter multiple attractive or repul-
sive guidance cues, sometimes simultaneously, along their
trajectory. The complexity of integrating signals from multiple
guidance cues is perhaps best exemplified by axons crossing
the ventral midline of the spinal cord (Colamarino and Tessier-
Lavigne, 1995). In this paradigm, axons of commissural neurons
in the dorsal spinal cord are initially attracted ventrally by
long-range gradients of Netrin and Shh secreted from the floor
plate, a specialized structure localized in the ventral spinal
cord. Once commissural axons invade the floor plate, their
sensitivity to attractive cues is silenced and axons are repelled
to the contralateral side by floor plate-derived repulsive cues,
including Slits and Sema3B (Che´dotal, 2011). Thus, intermediate
targets such as the floor plate express precise patterns of
attractive and repulsive cues that function at long and short
distances to orchestrate growth cone steering events that
underlie the establishment of accurate axonal trajectories.
How precisely patterned gradients of secreted guidance cues
form in vivo is not well understood, although components of
the extracellular matrix (ECM) are likely to play an essential
role. In principle, components of the ECM can influence interac-
tions between secreted cues and their receptors in several
ways, including controlling cue diffusion, concentrating cues in
particular locales, affecting ligand-receptor binding affinity,
modulating ligand or receptor processing, or influencing ligand
stability (Lee and Chien, 2004; Mu¨ller and Schier, 2011). In
Drosophila, ECM components have well-established roles in
generating gradients of secreted morphogens in vivo (Yan and
Lin, 2009). Furthermore, the localization of Slit is regulated byNeuron 76, 931–944, December 6, 2012 ª2012 Elsevier Inc. 931
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Figure 1. A Forward Genetic Screen Iden-
tifies B3gnt1 and ISPD as Regulators of
Axon Guidance In Vivo
(A) A sample E11.5 embryo stained using the
whole-mount neurofilament assay.
(B) Lines 1157 and 9445 exhibit axon guidance
defects in the hindbrain, highlighted by the boxed
area in (A). Control embryos have a tightly fascic-
ulated axon bundle (arrows) that passes dorsally to
the vagal nuclei. In contrast, 1157/1157 embryos
exhibit defasciculation of this axonal tract, while in
9445/9445 embryos the axon tract is missing, and
the central projections of the vagal nerve project
aberrantly. Conditional deletion of dystroglycan
(Sox2cre; DGF/) results in an identical phenotype
to line 9445 embryos, with an underdeveloped
hindbrain axonal fascicle andmisprojections of the
vagal central projections.
(C) Representative sequencing data from wild-
type C57BL/6 and 1157/1157 embryos showing
the T > C mutation in B3gnt1 that results in
conversion of a methionine to threonine at position
155 (M155T). A schematic of B3gnt1 protein
structure highlights the location of the M155T
mutation in the putative catalytic domain.
(D) Representative sequencing data from wild-
type C57BL/6 and 9445/9445 embryos showing
the T > A mutation in ISPD that results in conver-
sion of a leucine to a stop codon (L79*), resulting in
an early truncation.
(E) Axons fromdorsal root ganglia sensory neurons
normally bifurcate and project along the anterior-
posterior axis of the dorsal spinal cord as a tightly
fasciculated bundle, as seen in control embryos
at E13. In contrast, the dorsal funiculus in
B3gnt1Lacz/M155T, ISPDL79*/L79*, andSox2cre; DGF/
mutants is highly defasciclulated, with large
patches devoid of axons (white arrows).
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Dystroglycan and Axonal Guidancethe proteoglycan syndecan in Drosophila and the ECM protein
Collagen IV in zebrafish (Johnson et al., 2004; Xiao et al.,
2011). How specific ECM components affect guidance cue
distribution and function in vivo in the developing mammalian
nervous system is largely unknown.
Using a forward genetic screen in mice, we have identified two
genes, b-1,3-N-acetyl-glucosaminyltransferase-1 (B3gnt1) and
Isoprenoid synthase domain containing (ISPD), as regulators of
axon guidance. We show that B3gnt1 and ISPD are essential
for glycosylation of the extracellular matrix protein dystroglycan
in vivo and that B3gnt1 and ISPD mutants develop severe
neuronal migration defects commonly associated with defective
dystroglycan function. We find that dystroglycan is also required
for spinal cord basement membrane integrity and that axon
tracts growing in close proximity to the basement membrane
are severely disorganized in B3gnt1, ISPD, and dystroglycan
mutants. Remarkably, we find that glycosylated dystroglycan932 Neuron 76, 931–944, December 6, 2012 ª2012 Elsevier Inc.also binds directly to the axon guidance
cue Slit to organize its protein distribu-
tion in the floor plate and the basement
membrane, thereby regulating Slit-
mediated axon guidance. These findingsreveal a fundamental role for dystroglycan in organizing axon
guidance cue distribution and function within the ECM and iden-
tify novel mechanisms underlying human pathologies.
RESULTS
A Forward Genetic Screen Identifies B3gnt1, ISPD, and
Dystroglycan as Regulators of Axon Guidance
Weconducted anENU-based, three-generation, forward genetic
screen in order to identify mutations that affect the organization
of PNS and CNS axonal tracts (Merte et al., 2010; see Figure S1
available online). Utilizing a recessive breeding strategy, axonal
tracts of E11.5–12.5 embryos were visualized using a whole-
mount anti-neurofilament-based assay (Figure 1A). Screening
of 235 G1 mouse lines led to the identification of 10 distinct lines
harboring mutations resulting in axon guidance and axon
branching defects (Figures 1B and 1E; data not shown).
Neuron
Dystroglycan and Axonal GuidanceLines 1157 and 9445 were initially identified based on similar
defects in the development of longitudinal axonal tracts in the
hindbrain. In control embryos, axons emanating from the
midbrain and cranial nerves project caudally to cervical levels
of the spinal cord, forming a tightly fasciculated axon bundle
that passes through the hindbrain. In line 1157 mutant embryos,
these projections were truncated and defasciculated at the level
of the vagal complex (Figure 1B). Line 9445 mutants showed
a more severe phenotype, with the descending projections
failing to project through the hindbrain altogether, and the central
projections of the vagal complex projecting aberrantly within the
hindbrain (Figure 1B).
Genetic mapping localized the mutation in line 1157 to a gene
dense 6.5Mb region onChromosome 19. Targeted exon capture
coupledwith next-generation sequencing was used to sequence
the coding exons within this region of interest. Of the 255 genes
sequenced, we identified a single mutation, a T to C transversion
in exon 1 of b-1,3-N-Acetylglucosaminyltransferase 1 (B3gnt1),
which results in a methionine to threonine (M155T) substitution
in the B3gnt1 amino acid sequence (Figure 1C). B3gnt1 encodes
a glycosyltransferase, and the M155T mutation in B3gnt1 lies
within the N-terminal portion of the catalytic domain (Figure 1C).
Expression of myc-B3gnt1 in COS7 cells shows that this protein
normally localizes to the Golgi apparatus (Figure S2A, top
panels). In contrast,myc-B3gnt1M155T is not localized to theGolgi
but shows a high degree of overlap with the endoplasmic retic-
ulummarker PDI (FiguresS2AandS2B, bottompanels), suggest-
ing it is misfolded and retained in the ER. To verify that the
B3gnt1M155T mutation causes the axon guidance phenotype in
line 1157 mutants, we generated a targeted knockout mouse
line in which the B3gnt1 coding sequences were replaced with
LacZ (B3gnt1LacZ). Genetic complementation experiments
showed that transheterozygous B3gnt1LacZ/M155T mice exhibit
axon defasciculation in the descending hindbrain projections
(data not shown), confirming that themutation inB3gnt1 is indeed
the cause of the axon guidance defects observed in line 1157.
Genetic mapping of line 9445 localized the mutation to a 4.3
Mb region on Chromosome 12 that contains 18 genes. PCR
amplification and sequencing of the coding exons of all 18 genes
identified a single mutation, a T to A transversion, in exon 1 of the
gene Isoprenoid Synthase Domain Containing (ISPD), which
results in a conversion of a leucine to a premature stop codon
(L79*) (Figure 1D). ISPD encodes a protein with homology to
the bacterial protein IspD, a cytidyltransferase that functions in
the methylerythritol phosphate (MEP) pathway of isoprenoid
synthesis, which is not present in vertebrates (Richard et al.,
2004).
Further analysis of the axon guidance phenotypes of
B3gnt1LacZ/M155T and ISPDL79*/L79* embryos identified defects
in the formation of the dorsal funiculus by the central projec-
tions of dorsal root ganglia (DRG) sensory neurons. In control
embryos, the dorsal funiculus forms along the dorsal aspect of
the spinal cord as a tightly fasciculated bundle. In contrast, the
dorsal funiculus in both B3gnt1LacZ/M155T and ISPDL79*/L79*
mutants is highly defasciculated and exhibits a patchy and
discontinuous appearance (Figure 1E).
The phenotypic similarities between the B3gnt1 and ISPD
mutants raised the intriguing possibility that they function in thesame genetic pathway to regulate axon guidance. B3gnt1 has
been implicated as a dystroglycan glycosyltransferase in tumor
cell lines in vitro (Bao et al., 2009), and mutations in ISPD were
recently identified in patients with Walker-Warburg syndrome,
a neurodevelopmental disorder characterized by defective
glycosylation of dystroglycan (Roscioli et al., 2012; Willer et al.,
2012). While dystroglycan is known to be required for neuronal
migration in the brain, it has not previously been implicated in
regulating axon guidance. To determine if the axon guidance
defects observed inB3gnt1 and ISPDmutants are due to defects
in dystroglycan function, we generated mice in which dystrogly-
can was deleted from the epiblast (Sox2cre; DGF/) to circumvent
the early embryonic lethality associated with germline deletion of
dystroglycan. Indeed, Sox2cre; DGF/ mice exhibit the same
axon guidance defects as B3gnt1 and ISPD mutants, with
abnormal formation of the descending hindbrain axonal tract
and severe defasciculation of the spinal cord dorsal funiculus
(Figures 1B and 1E). These findings thus reveal a requirement
for dystroglycan in regulating axon guidance.
B3gnt1 and ISPD Mutants Are Mouse Models
of Dystroglycanopathy
Dystroglycan functions in vivo in the assembly and maintenance
of basement membranes by acting as a receptor and scaffold for
several ECM proteins (Barresi and Campbell, 2006). Dystrogly-
can undergoes extensive glycosylation in vivo, and ligand
binding to dystroglycan is strictly dependent on its proper glyco-
sylation. Importantly, human patients with mutations in dystro-
glycan or its glycosyltransferases develop a spectrum of
congenital muscular dystrophies that are often accompanied
by a range of neurological defects. These disorders are collec-
tively referred to as dystroglycanopathies, and their pathological
hallmarks are recapitulated in mouse models with deletions in
orthologous genes (Hewitt, 2009; Moore et al., 2002; Satz
et al., 2008). Interestingly, several studies indicate that the
majority of human patients with pathological defects in dystro-
glycan glycosylation have mutations of unknown etiology, sug-
gesting that additional unknown glycosyltransferases are
required for dystroglycan function in vivo (Mercuri et al., 2009).
While B3gnt1M155T/M155T mice are born at normal Mendelian
ratios and display a mild muscular dystrophy phenotype of vari-
able penetrance, B3gnt1LacZ/LacZ embryos failed to survive
beyond E9.5, indicating that B3gnt1 is required for normal
embryonic development and that the M155Tmutation generates
a hypomorphic allele. B3gnt1LacZ/LacZ early embryonic lethality is
consistent with a role for B3gnt1 in regulating dystroglycan
glycosylation and function in vivo, since mice deficient for
dystroglycan die around E7.5 due to defects in Reichert’s
membrane, the basement membrane situated between the
trophoblast and parietal endoderm cells of early mammalian
embryos (Williamson et al., 1997). To circumventB3gnt1LacZ/LacZ
early embryonic lethality, we conducted all subsequent analyses
using B3gnt1LacZ/M155T mice. The majority of B3gnt1LacZ/M155T
mice die perinatally, but the few that do survive to adulthood
develop symptoms characteristic of congenital muscular
dystrophy, displaying a hunched posture, hindlimb clasping,
and atrophic musculature (Figures S3A and S3B). Immunostain-
ing of skeletal muscle from B3gnt1LacZ/M155T mice shows severeNeuron 76, 931–944, December 6, 2012 ª2012 Elsevier Inc. 933
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amination of membrane-enriched extracts isolated from
B3gnt1LacZ/M155T skeletal muscle revealed that glycosylated
alpha-dystroglycan is reduced to a nearly undetectable
amount, while the level of total dystroglycan protein is normal
(Figure S3D). Consistent with the inability of hypoglycosylated
dystroglycan to bind ligand, extracts from B3gnt1LacZ/M155T
mice are deficient for laminin binding (Figure S3D).
While a complete loss of B3gnt1 results in early embryonic
lethality, ISPDL79*/L79* embryos were obtained at normal
Mendelian ratios up to E18, suggesting that ISPD function is
not required for formation of Reichert’s membrane. However,
all ISPDL79*/L79* mutants that were born died at P0 due to
apparent respiratory failure, preventing any analysis of a
muscular dystrophy phenotype.
In the central nervous system, deletion of dystroglycan or its
glycosyltransferases results in neuronal migration defects
similar to type II (cobblestone) lissencephaly. Examination of
membrane-enriched extracts from B3gnt1LacZ/M155T and
ISPDL79*/L79* brains revealed that while the levels of total dystro-
glycan protein are normal, glycosylated alpha-dystroglycan and
laminin binding activity are reduced to an undetectable amount
(Figures 2A and 2B). In the cortex of control embryos, glycosy-
lated dystroglycan expression is enriched in radial glial endfeet
where it binds to extracellular matrix proteins to organize and
maintain the basement membrane along the basal cortical
surface (Figure 2C). In the cortex of B3gnt1LacZ/M155T and
ISPDL79*/L79* mice, dystroglycan glycosylation is lost, leading
to a loss of laminin accumulation in the basement membrane
(Figure 2C). Previous analysis of mice in which dystroglycan
was conditionally deleted from radial glia observed neuronal
migration defects in regions where radial glia endfeet had
detached from the basement membrane (Satz et al., 2010).
B3gnt1LacZ/M155T and ISPDL79*/L79* mice show similar migration
defects in the cortex, exhibiting radial glial endfoot detach-
ment and neuronal heterotopias similar to those found in
cobblestone lissencephaly (Figures 2C and S4A; data not
shown). Analysis of surviving adult B3gnt1LacZ/M155T mice
showed that they also exhibit neuronal migration defects in the
cerebellum and hippocampus and develop hydrocephaly
(Figure S4B, data not shown). Taken together, these defects
confirm that B3gnt1 and ISPD function in the same genetic
pathway to regulate dystroglycan glycosylation in vivo, and
establish B3gnt1LacZ/M155T and ISPDL79*/L79* mice as mouse
models of dystroglycanopathy.
Dystroglycan Is Required for Basement Membrane
Integrity in the Developing Spinal Cord
The defects observed in B3gnt1, ISPD, and dystroglycan
mutants suggests a role for dystroglycan in mediating axon
guidance in vivo. The axons of both the descending hindbrain
projections and the dorsal funiculus extend along the basal
surface of the hindbrain and spinal cord, respectively, suggest-
ing that dystroglycan may be required in the hindbrain and
spinal cord for the proper development of these axonal
tracts. In contrast to the well-characterized role of dystroglycan
in the developing cortex, its function in the spinal cord is
unclear. Similar to the developing cortex, levels of total dystro-934 Neuron 76, 931–944, December 6, 2012 ª2012 Elsevier Inc.glycan protein in the spinal cord of B3gnt1LacZ/M155T and
ISPDL79*/L79* mutants are normal, while glycosylated alpha-dys-
troglycan and laminin binding activity are reduced to an unde-
tectable amount (Figures 3A and 3B). Examination of dystrogly-
can localization in the spinal cord by immunostaining shows
that dystroglycan is enriched in the radial neuroepithelial end-
feet, where it colocalizes with several extracellular matrix
proteins including laminin, perlecan, and collagen IV to form
a continuous basement membrane surrounding the spinal
cord (Figures 3C and S5A). In B3gnt1LacZ/M155T, ISPDL79*/L79*
and Sox2cre; DGF/ embryos, the loss of functional dystro-
glycan results in the progressive fragmentation of the base-
ment membrane beginning around E11.5 which is accompanied
by detachment of radial neuroepithelial endfeet from the
basal surface (Figures S5A and S5B). This fragmentation
first appears in the lateral portion of the spinal cord and prog-
resses ventrally and dorsally as the spinal cord continues to
develop.
Dystroglycan Is Required for Commissural Axon
Crossing in the Spinal Cord
Interestingly, in addition to its localization to the basement
membrane surrounding the spinal cord, we found that dystrogly-
can is enriched in the floor plate, a specialized glial structure in
the ventral neuraxis that spans the CNS anteroposterior axis
from the midbrain to caudal spinal cord (Figures 3C and 3D).
The spinal cord floor plate functions both as an organizer of
ventral cell fates and as an intermediate target for commissural
axons whose cell bodies reside within the dorsal spinal cord.
The axons of commissural neurons are initially attracted
ventrally to the floor plate by a number of floor plate derived
cues, including Netrin, Shh, and VEGF (Charron et al., 2003;
Ruiz de Almodovar et al., 2011; Serafini et al., 1996). Once
commissural axons reach the floor plate, these attractive cues
are silenced and repulsive floor plate-derived cues, including
Slits (Long et al., 2004) and Sema3B (Zou et al., 2000), force
axons out of the floor plate and into the contralateral side of
the spinal cord, where they turn rostrally and extend in close
proximity to the basement membrane to form the ventrolateral
funiculus.
Since enrichment of dystroglycan in the floor plate is similar to
Slit and other axon guidance cues, we hypothesized that dys-
troglycan regulates guidance of commissural axons as they
cross the ventral midline. Analysis at E11.5, a time when axons
are beginning to project through the floor plate, revealed minor
disruptions in the glial structures and the basement membrane
within the floor plate in the absence of dystroglycan (Fig-
ure S5B). In control E11.5 embryos, commissural axons labeled
with an antibody to L1 project through the floor plate and
turn rostrally, forming the ventrolateral funiculus (Figures
4A–4D). In contrast, commissural axons in B3gnt1LacZ/M155T,
ISPDL79*/L79*, and Sox2Cre; DGF/ mutant embryos exhibit
robust postcrossing trajectory defects (Figures 4A–4D). These
axons fail to project to the lateral portion of the funiculus, and
quantification revealed that the ratio of the areas occupied by
the lateral and ventral funiculi is significantly altered in
B3gnt1LacZ/M155T, ISPDL79*/L79*, and Sox2Cre; DGF/ embryos
(Figure 4E). This failure of postcrossing commissural axons to
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Figure 2. B3gnt1 and ISPD Mutants Have Defective Glycosylation of Dystroglycan and Develop Cobblestone Lissencephaly
(A and B) WGA-enriched brain lysates show a loss of dystroglycan glycosylation (IIH6) in B3gnt1Lacz/M155T and ISPDL79*/L79* mutants compared to control
embryos, while total dystroglycan levels (b-dystroglycan) remain normal. Lysates from B3gnt1LacZ/M155T and ISPDL79*/L79* mutants are also defective for laminin
binding. Quantification of western blots was done using samples from multiple embryos from separate litters (n = 3). Data are represented as mean ±SD (n = 3).
Statistical analysis was done using a Student’s t test, *p < 0.001.
(C) Immunostaining of cortical sections shows a loss of glycosylated dystroglycan (IIH6, green) and laminin (red) along the basal surface in B3gnt1LacZ/M155T and
ISPDL79*/L79 mutants. Nuclear staining (blue) revealed extensive cortical migration defects characteristic of cobblestone lissencephaly in B3gnt1LacZ/M155T and
ISPDL79*/L79* mutants (dotted lines).
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Figure 3. Glycosylation of Dystroglycan Is Defective in the Spinal Cord of B3gnt1LacZ/M155T Embryos
(A and B) WGA-enriched spinal cord lysates show deficient dystroglycan glycosylation (IIH6) in B3gnt1Lacz/M155T and ISPDL79*/L79* mutants compared to control
embryos, while total dystroglycan levels (b-dystroglycan) remain normal. Lysates from B3gnt1LacZ/M155T and ISPDL79*/L79* mutants are also defective for laminin
binding. Quantification of western blots was done using samples from multiple embryos from separate litters (n = 3). Data are represented as mean ±SD (n = 3).
Statistical analysis was done using a Student’s t test, *p < 0.001.
(C) Immunostaining of spinal cords from E11.5 control, B3gnt1LacZ/M155T, and ISPDL79*/L79* embryos showed that b-dystroglycan expression (red, top panels) is
enriched in along the basement membrane surrounding the spinal cord and in the floor plate. In contrast, glycosylated dystroglycan expression (IIH6, green,
bottom panels) is deficient in the B3gnt1LacZ/M155T and ISPDL79*/L79* embryos compared to controls (n = 3).
(D) In situ hybridization shows that dystroglycanmRNA (left andmiddle panels) is expressed in the midline and overlaps with the expression of Slit1 (right panel) in
the floor plate of E12.5 spinal cord (n = 3). Scale bar represents 100 mM.
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   Figure 4. Dystroglycan Is Required for
Spinal Cord Commissural Axon Crossing
and Development of the Ventrolateral
Funiculus
(A–C) Spinal cords from E11.5 (A) B3gnt1LacZ/WT
and B3gnt1LacZ/M155T (n = 5), (B) ISPDL79*/WT and
ISPDL79*/L79* (n = 4), (C) Sox2cre; DGF/+ and
Sox2cre; DGF/ (n = 3), and (D)Robo1+/;Robo2+/
and Robo1/; Robo2/ (n = 3) embryos were
immunostained for L1 to label post-crossing
commissural axons.
(E) The area occupied by axons in the ventral
funiculus and the lateral funiculus was quanti-
fied, expressed as a ratio of LF/VF area and
normalized to controls. Data are represented as
mean ± SD.
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Dystroglycan and Axonal Guidanceproject into the lateral portion of the funiculus is remarkably
similar to the phenotype observed in Robo1/2 knockout mice
(Figures 4D and 4E; Jaworski et al., 2010). Analysis of post-
crossing commissural axons two days later at E13.5 revealed
that in addition to the lateral-to-ventral shift in axonal trajectory,
B3gnt1 and dystroglycan mutants also exhibit extensive disrup-
tions in the more lateral aspect of the ventrolateral funiculus as
axons project along the basement membrane, a phenotype
that is not observed in control or Robo1/2 mutants (Figures
S6A–S6D).
Examination of the floor plate in E13 B3gnt1LacZ/M155T,
ISPDL79*/L79*, and Sox2Cre; DGF/ embryos at higher magnifica-
tion revealed a large number of commissural axons projecting
abnormally within the floor plate (Figure 5A, arrows). To better
characterize the nature of these commissural axon misprojec-
tions, we used DiI labeling in an open-book preparation to unilat-
erally label small populations of commissural neurons and their
axonal projections (Long et al., 2004). In control embryos,Neuron 76, 931–944,commissural axons were observed
crossing the floor plate (dashed lines)
and turning rostrally after exiting the floor
plate (Figure 5B). In stark contrast, many
commissural axons in B3gnt1LacZ/M155T,
ISPDL79*/L79*, and Sox2Cre; DGF/
embryos stalled within the floor plate.
The axons that did exit the floor plate
showed abnormal turning behaviors,
exhibiting random turning (extending
either rostrally and caudally) and/or failing
to turn at all (Figure 5B). Quantification
of commissural axon turning behaviors
at several different axial levels of the
spinal cord showed that axons in
greater than 80% of DiI labeled sites
in control embryos turn rostrally after
floor plate crossing, whereas axons in
fewer than 10% of DiI labeled sites
exhibit this behavior in B3gnt1LacZ/M155T,
ISPDL79*/L79, and Sox2Cre; DGF/ em-
bryos. These findings establish an essen-
tial role for glycosylated dystroglycan inregulating axon guidance at the ventral midline of the spinal
cord in vivo.
Dystroglycan Binds Slit to Regulate Axon Guidance in
the Floor Plate
The commissural axon guidance phenotypes observed in the
B3gnt1, ISPD and dystroglycan mutants raised the possibility
that dystroglycan binds to axon guidance cues within the floor
plate to regulate their function. Previous studies have identified
a number of ligands that bind directly to dystroglycan in
a glycosylation-dependent manner, including laminin, agrin,
perlecan, neurexin, and pikachurin (Gee et al., 1994; Sato
et al., 2008; Sugita et al., 2001; Talts et al., 1999). A common
feature of these ligands is the presence of a laminin G (LG)
domain that mediates their association with carbohydrate moie-
ties present on glycosylated dystroglycan. Intriguingly, of the
axon guidance cues known to be expressed in the floor plate,
Slits contain an LG domain within their C-terminal regions.December 6, 2012 ª2012 Elsevier Inc. 937
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Figure 5. Postcrossing Trajectory of Commissural Axons Is Disrupted in B3gnt1, ISPD, and dystroglycan Mutants
(A) High magnification images from the floor plate of E13 B3gnt1LacZ/M155T (n = 7), ISPDL79*/L79* (n = 3), and Sox2Cre; DGF/(n = 3) embryos showed L1 positive
axons aberrantly projecting within the floor plate (white arrows), in contrast to control embryos (n = 5). Scale bar represents 25 mM.
(B) DiI injections were performed to unilaterally label commissural axons, and postcrossing axonal trajectory was scored as normal, stalled, straight, or random
(indicative of both anterior and posterior turning). Axons from control embryos turned anteriorly (up in images) after crossing the floor plate (dashed white lines),
whereas axons fromB3gnt1LacZ/M155T, ISPDL79*/L79*, and Sox2Cre; DGF/ embryos showed abnormal axonal trajectories (white arrows) at all axial levels. Scale bar
represents 50 mM. Quantification of axonal trajectory is from three spinal cords per genotype, with at least ten injections per spinal cord.
Neuron
Dystroglycan and Axonal GuidanceThus, the overlapping expression patterns of dystroglycan and
Slits in the floor plate, the similarities in axon guidance pheno-
types observed in the B3gnt1, ISPD, dystroglycan, and Slit/
Robo mutants, and the presence of an LG domain in the Slit C938 Neuron 76, 931–944, December 6, 2012 ª2012 Elsevier Inc.terminus, led us to hypothesize that glycosylated dystroglycan
binds directly to Slits to regulate their function.
We first asked whether dystroglycan can bind directly to the
C-terminal region of Slit, which harbors the LG domain, using
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Figure 6. Dystroglycan Binds to the
C-Terminal Region of Slit via the Slit Laminin
G Domain
(A) COS7 cells transfected with full-length dystro-
glycan (top panels) or Robo-1 (bottom panels)
were incubated with either AP-Slit2 LRR (con-
taining the Robo binding domain, right panels) or
AP-Slit2 C terminus (containing the Laminin G
motif, left panels). Robo transfected cells bound to
AP-Slit2 LRR, but not the AP-Slit2 C terminus,
whereas dystroglycan transfected cells bound the
AP-Slit2 C terminus, but not to AP-Slit2 LRR
(n = 3). Scale bars represent 25 mM.
(B) Fc-tagged a-dystroglycan secreted from
COS7 cells was incubated with supernatant con-
taining either secreted AP-Slit2 LRR or AP-Slit2 C
terminus, both of which contain a C-terminal myc
tag. DG-Fc was able to associate with AP-Slit2 C
terminus, but not AP-Slit2 LRR (n = 3).
(C) Secreted AP-Slit2 LRR or AP-Slit2 C terminus
were incubated with WGA-enriched brain lysate,
and complexes were purified using Ni-NTA beads.
Endogenous brain dystroglycan associates with
Slit2 C terminus, but not Slit2 LRR (n = 4).
(D) Crystal structure of LG5 from Laminin a1, with
a bound Ca2+ in blue, and the basic residues
corresponding to K1177 and K1179 in the LG
domain of Slit2 highlighted in red.
(E) DG-Fc association with AP-Slit2 C terminus
requires divalent cations, as addition of EDTA
abolished binding (black arrow, n = 3).
(F) Mutation of basic residues adjacent to the
Ca2+ binding site (K1177A, K1179A) in the Slit2
C terminus results in a loss of binding to DG-Fc
(n = 3).
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Dystroglycan and Axonal Guidancean in vitro COS7 cell-binding assay. We generated constructs in
which alkaline phosphatase (AP) is fused to either the Robo-
binding leucine rich repeat domain 2 of Slit2 (AP-LRR) or the
C-terminal region containing the LG domain of Slit2 (AP-Cterm).
As expected, COS7 cells transfected with a construct encoding
full-length Robo-1 specifically bind to AP-LRR, but not to AP-
Cterm or AP alone (Figure 6A, data not shown). Importantly,
COS7 cells expressing full-length dystroglycan showed robust
binding to AP-Cterm but not to AP-LRR or AP alone. These find-
ings demonstrate that dystroglycan is capable of binding to the
Slit C-terminal domain. To further test direct binding between
dystroglycan and Slit, we generated an Fc-dystroglycan protein
secreted from COS7 cells and determined whether it is capable
of direct association with the different domains of Slit. We find
that while Fc-dystroglycan fails to bind to AP-LRR, it does bind
to AP-Cterm (Figure 6B). We next asked whether the Slit
C-terminal fragment is able to bind to endogenous dystroglycan.Neuron 76, 931–944,Dystroglycan enriched membrane frac-
tions isolated by WGA precipitation from
mouse brain lysates were incubated
with either AP-LRR or AP-Cterm. Indeed,
the Slit C-terminal fragment, but not the
Slit LRR, is able to associate with endog-
enous dystroglycan (Figure 6C).Previous studies indicate that the binding of laminin LG
domains to dystroglycan requires a basic patch surrounding
a Ca2+ binding site (Harrison et al., 2007). Alignment of the
Slit2 LG domain with the known structure of laminin a1
LG5 identified a putative Ca2+ binding site surrounded by
several basic residues (Figure 6D). We found that binding of
the Slit C-terminal domain to dystroglycan requires Ca2+, since
addition of EDTA is sufficient to abolish this Slit-dystroglycan
interaction (Figure 6E). Moreover, a version of the Slit2
C-terminal domain in which two basic residues adjacent to
the Ca2+ binding site are mutated to alanine (K1177A,
R1179A, referred to here as Slit2 C-term AVA) is incapable of
binding to Fc-dystroglycan (Figure 6F). Thus, the Slit2 LG
domain mediates its association with dystroglycan and,
similar to other LG modules, the Slit2 LG domain requires
a Ca2+ binding site surrounded by a basic patch for this
interaction.December 6, 2012 ª2012 Elsevier Inc. 939
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(A) Spinal cord sections from B3gnt1LacZ/WT and
B3gnt1LacZ/M155T embryos were incubated with
AP-Slit2 C terminus to identify endogenous
binding sites in vivo. The Slit2 C terminus bound
specifically to regions of dystroglycan expression
in tissue sections from B3gnt1LacZ/WT embryos,
including the basement membrane surrounding
the spinal cord and the floor plate (arrows, left
panel). In contrast, Slit2 C terminus binding to the
basement membrane and floor plate is absent
in B3gnt1LacZ/1157 embryos (arrows, right panel)
(n = 4).
(B) To detect the localization of endogenous Slit
protein in vivo, spinal cord sections from
B3gnt1LacZ/WT (left panels) and B3gnt1LacZ/M155T
(right panels) embryos were incubated with AP-
Robo. Binding of AP-Robo is detected in the floor
plate and in a gradient along the basal surface of
the spinal cord of B3gnt1LacZ/WT embryos (arrows,
left panel), and this binding is absent in the spinal
cord of B3gnt1LacZ/M155T embryos (arrows, right
panel) (n = 3). Scale bar represents 100 mM.
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raise the intriguing possibility that dystroglycan present in the
floor plate and basement membrane serves as a scaffold for
the proper localization of Slit in vivo. Consistent with this idea,
dystroglycan and slit are required for proper cardiac tube forma-
tion in Drosophila, and Slit protein appears to be mislocalized in
dystroglycan mutant cardioblasts (Medioni et al., 2008). We first
verified that the expression patterns of Slit1 and Slit2mRNA are
indistinguishable in control and B3gnt1 mutants (Figure S7A),
demonstrating that dystroglycan is not required for floor plate
development or expression of these axonal guidance cues. To
test whether dystroglycan regulates Slit localization, an AP-
section binding assay was employed to visualize the location
of endogenous C-terminal Slit binding sites in vivo. Incubation
of transverse spinal cord sections from E11 control embryos
with the AP-Slit C-term ligand showed robust binding to the
basement membrane surrounding the spinal cord and the floor
plate (Figure 7A), regions that are enriched for dystroglycan
protein expression (Figures 3C and 3D). Importantly, binding of
AP-Slit C-term is absent in B3gnt1LacZ/M115T mutants, demon-
strating that glycosylation of dystroglycan is essential for Slit
C-terminal domain binding in vivo.
Since Slit binds directly to glycosylated dystroglycan via its
C-terminal LG domain, we hypothesized that dystroglycan
present in both the floor plate and basement membrane are940 Neuron 76, 931–944, December 6, 2012 ª2012 Elsevier Inc.required for organization of endogenous
Slit proteins within these locations.
Therefore, we developed a method to
assess the sites of Slit protein localization
in tissue sections to ask whether loss of
glycosylated dystroglycan in the B3gnt1
mutants alters the distribution of endoge-
nous Slit protein in vivo. The lack of
antibodies suitable for mammalian Slitimmunolocalization necessitated the development of an alter-
nate approach. Therefore, we modified the AP-ligand section
binding assay by using an AP-Robo ectodomain fusion protein
that is capable of binding to Slit protein on tissue sections
(Jaworski and Tessier-Lavigne, 2012). AP-Robo bound specifi-
cally in the floor plate and in close proximity to the ventrolateral
funiculus formed by postcrossing commissural axons (Fig-
ure 7B). In contrast, AP-Robo binding sites are strikingly defi-
cient in both the floor plate and ventrolateral funiculus in sections
fromB3gnt1mutants. These findings demonstrate that the in vivo
distribution of endogenous Slit protein is dependent upon
glycosylated dystroglycan, providing an explanation for the
Slit/Robo-like phenotypes in B3gnt1, ISPD, and dystroglycan
mutants and therefore insight into the mechanistic basis under-
lying axon guidance defects in mice, and presumably humans,
with dystroglycanopathies.
DISCUSSION
We report here that B3gnt1 and ISPD are required for dystrogly-
can glycosylation in vivo and that glycosylated dystroglycan is
required for proper guidance and development of several axonal
tracts. We identified two mechanisms by which dystroglycan
regulates axon guidance. First, dystroglycan is required for the
integrity of basement membranes that developing axonal tracts
Neuron
Dystroglycan and Axonal Guidanceextend along, thereby maintaining a permissive growth environ-
ment. Second, we found that dystroglycan binds directly to the
laminin G domain of Slit, thereby organizing Slit protein dis-
tribution in vivo. Therefore, dystroglycan likely functions as an
extracellular scaffold that controls axon guidance events by
organizing the availability of axonal growth and guidance cues
at critical intermediate targets. Furthermore, our findings
suggest that misregulation of Slit-Robo signaling contributes to
axonal guidance and neuronal connectivity defects in human
patients with dystroglycanopathies.
B3gnt1 and ISPD Mutants Are Models
of Dystroglycanopathy
Glycosylated dystroglycan is required for the organization of
ECM proteins in basement membranes. Mutations that disrupt
glycosylation of dystroglycan and result in dystroglycanopthies
in humans have been identified in seven genes: POMT1,
POMT2, POMGnt1, Fukutin, FKRP, LARGE, and recently ISPD
(Hewitt, 2009; Roscioli et al., 2012; Willer et al., 2012). However,
the molecular etiology of many patients with dystroglyca-
nopthies is unknown, suggesting that additional unidentified
genes are required for dystroglycan glycosylation (Mercuri
et al., 2009). Through our forward genetic screen in mice, we
identified B3gnt1 and ISPD mutants as mouse models for
dystroglycanopathy.
Genetic and biochemical findings demonstrate exten-
sive heterogeneity in the glycosylation of dystroglycan which,
although it has a predicted molecular mass of 72 kD, exhibits
an apparent molecular mass that ranges from 120 kD in cortex
and peripheral nerve to 160 kD in skeletal muscle and 180 kD
in the cerebellar Purkinje neurons (Satz et al., 2010). While this
heterogeneity has made the precise composition of the glycan
side chains on dystroglycan difficult to ascertain, dystroglycan
isolated from mouse brain contains both O-GalNAc- and
O-Mannose-initiated glycan side chains that require POMT1,
POMT2, and POMGnt1 for their synthesis (Stalnaker et al.,
2011). Recent studies indicate that LARGE functions as both
a bifunctional xylosyltransferase and glucuronyltransferase
(Inamori et al., 2012), while the enzymatic functions of Fukutin
and FKRP have yet to be elucidated. Likewise, the enzymatic
steps catalyzed by B3gnt1 and ISPD in the production of mature,
fully glycosylated dystroglycan is presently unknown. The
B3gnt1 and ISPD mutant mice should provide useful tools for
resolving this issue. Interestingly, analysis of the subcellular
localization of Fukutin revealed that while the wild-type protein
localizes to the Golgi, several disease-causing missense muta-
tions in Fukutin result in a protein that is aberrantly localized to
the ER (Tachikawa et al., 2012). Similarly, while wild-type
B3gnt1 is associated with the Golgi, the M155T mutation results
in B3gnt1 mislocalization to the ER, suggesting that this mis-
sense mutation may result in improper folding of B3gnt1 leading
to its impaired function in vivo (Figure S2).
It is interesting to note that although we were unable to detect
any glycosylated dystroglycan in ISPD mutants and these
mutants appeared to fully phenocopy Sox2cre; DGF/ mutants,
ISPDmutantswere able to survive until birth, strongly suggesting
that ISPD function is not required for formation of Reichert’s
membrane. This is unique among genes required for dystrogly-can glycosylation, as complete loss-of-function mutations in
these genes, with the exception of POMGnt1, leads to loss of
Reichert’s membrane and early embryonic lethality.
Dystroglycan Is a Regulator of Slit-Robo Signaling
and Axon Guidance
Dystroglycan has awell-characterized role in regulating neuronal
migration in the developing brain since it is required for radial glia
endfoot attachment to the basement membrane surrounding the
brain. Our analysis of B3gnt1, ISPD, and dystroglycan mutant
mice reveals an additional, critical role for dystroglycan in the
development of several axonal tracts.
The prevailing model for axon guidance at the spinal cord floor
plate posits that axons are initially attracted to the floor plate by
long-range gradients of the chemoattractants Netrin and Shh,
and attraction is silenced and converted to repulsion once axons
reach the floor plate. Thus, precise spatial and temporal Slit
expression patterns are essential for proper commissural axon
midline crossing. The spinal cord commissural axon crossing
phenotypes observed in the B3gnt1, ISPD, and dystroglycan
mutants prompted us to ask whether glycosylated dystroglycan
regulates axon guidance at the ventral midline via modulation of
floor plate derived guidance cues. Indeed, we found that dystro-
glycan binds directly to the laminin G domain in the C-terminal
portion of Slit and that this interaction is required for the localiza-
tion of Slit protein at the floor plate where it guides commissural
axons across the midline. While there are differences in the axon
guidance phenotypes between the B3gnt1, ISPD, and dystrogly-
can mutants and the Slit or Robo mutants, we would not antici-
pate precisely the same phenotypes, as our model posits that
the loss of functional dystroglycan results in a mislocalization
of Slit from the floor plate and basement membranes, as
opposed to a complete loss of Slit-Robo signaling. Indeed, the
randomization of anterior-posterior postcrossing trajectories
observed in B3gnt1, ISPD, and dystroglycan mutants has not
been reported in either Slit or Robo mutants but is seen in
Sema3B/Npn2/Plexin-A1 and Wnt4/Fzd3 mutants (Lyuksyutova
et al., 2003; Nawabi et al., 2010; Zou et al., 2000), suggesting that
dystroglycan may organize additional floor plate or basement
membrane-associated axon guidance cues. Interestingly, con-
sistent with our observation of axonal guidance defects in
B3gnt1, ISPD, and dystroglycan mutants, postmortem analysis
of a patient with Walker-Warburg syndrome, a severe form of
dystroglycanopathy, revealed a reduction of the spinal cord
lateral funiculus (Kanoff et al., 1998). Together, these findings
suggest that defects in axon guidance cue signaling, including
Slit-Robo signaling, are contributing factors in the pathology of
human patients with dystroglycanopathies.
Basement Membrane Integrity Is Required for Axon
Guidance
In addition to guiding axonal projections at the floor plate through
interactions with Slit, we find that glycosylated dystroglycan
controls axon guidance through a second, distinct mechanism:
organization of basement membrane ECM components.
Although the role of ECM proteins in regulating axonal growth
and guidance has been well documented in vitro, an under-
standing of how these molecules regulate specific axonNeuron 76, 931–944, December 6, 2012 ª2012 Elsevier Inc. 941
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Dystroglycan and Axonal Guidanceguidance events in vivo is lacking. In Drosophila, Laminin A is
required for guidance of ocellar photoreceptor axons but not
the neighboring mechanosensory bristle axons, demonstrating
that different neuronal populations can have distinct ECM
requirements for axonal guidance in vivo (Garcı´a-Alonso et al.,
1996). Throughout the mammalian nervous system, glycosy-
lated dystroglycan localized near the endfeet of radial neu-
roepithelial cells serves as an essential scaffold for ECM
proteins, including laminin, perlecan, and collagen IV, to form
the basement membrane. The axons that form the dorsal funic-
ulus, ventrolateral funiculus, and descending hindbrain projec-
tions extend along the basal surface of the developing hindbrain
and spinal cord, in direct apposition to the basement membrane
(Figure S6E). The coincident disorganization of these axon
tracts and the disruption of the basement membrane compo-
nents laminin, perlecan, and collagen IV in B3gnt1, ISPD, and
dystroglycan mutants strongly suggests that development of
these axonal projections requires dystroglycan to organize the
ECM-rich basement membrane as a growth and guidance
substrate. Recent work has also implicated the basement
membrane in coordinating the localization of axon guidance
cues, including draxin in the developing spinal cord (Islam
et al., 2009) and collagen IV-dependent localization of Slit in
the optic tectum (Xiao et al., 2011). Thus, ECM components of
the basement membrane control proper growth and fascicula-
tion of major axonal fiber tracts in the developing nervous
system.
The Modular Structure of Slit Provides a Mechanism
for Spatial Restriction
Slits have a modular domain structure, with an N-terminal
domain containing the LRR regions required for Robo binding
and, as shown here, a C-terminal domain that mediates direct
association with dystroglycan. Slit proteins can be cleaved
both in vitro and in vivo, with both full-length Slits and their
N-terminal fragments exhibiting repulsive axon guidance
activity, while the Slit C-terminal domains have no effect on
axon repulsion in vitro (Brose et al., 1999; Nguyen Ba-Charvet
et al., 2001). However, the functional relevance of Slit cleavage
in vivo is unclear, as re-introduction of a non-cleavable form of
Slit into slit mutant Drosophila is able to rescue axon guidance
defects (Coleman et al., 2010). The modular structure of Slit is
particularly interesting with respect to its interaction with
heparan sulfate proteoglycans (HSPGs), which have a critical
role in mediating Slit-Robo signaling both in vitro (Hu, 2001)
and in vivo (Bu¨low et al., 2008; Inatani et al., 2003; Johnson
et al., 2004; Pratt et al., 2006; Steigemann et al., 2004). Biochem-
ical studies have identified a heparin binding site in the LRR
region of the N-terminal portion of Slit that stabilizes its interac-
tion with Robo, while a second high-affinity HS binding site is
located in the C-terminal domain (Hussain et al., 2006). The func-
tional significance of HSPG binding to the C-terminal portion of
Slit is unknown, but one interesting possibility is that the Slit-
HSPG interaction stabilizes the Slit C-terminal binding to
dystroglycan, similar to the role of heparin in stabilizing the
LRR-Robo interaction. These findings, taken together, reveal
the modular nature of Slit proteins, with separable Robo and
dystroglycan binding domains, and define a mechanism for942 Neuron 76, 931–944, December 6, 2012 ª2012 Elsevier Inc.establishing sites of ligand-receptor interactions that control
axonal guidance decisions with great spatial fidelity.
In summary, we have identified B3gnt1 and ISPD as required
for dystroglycan glycosylation and thus organization of ECM
components in vivo. Our analysis of B3gnt1, ISPD, and dystro-
glycan mutants reveals an essential role for glycosylated
dystroglycan in the development of several major axonal tracts
that grow along basement membranes, including the spinal
cord ventrolateral funiculus, dorsal funiculus, and descending
hindbrain projections. Dystroglycan binds directly to the
C-terminal laminin G domain of the axon guidance cue Slit,
and this interaction is essential for organizing Slit protein distri-
bution in both the basement membrane and spinal cord floor
plate and for the guidance of commissural axons. We propose
that axonal guidance defects resulting from aberrant axonal
guidance cue signaling, including aberrant Slit-Robo signaling,
contribute to the pathology of human dystroglycanopathies.
EXPERIMENTAL PROCEDURES
Forward Genetic Screen
The three-generation forward genetic screen and whole-mount neurofilament
staining assay were performed as described in detail (Merte et al., 2010).
Generation of B3gnt1LacZ Mice
B3gnt1LacZ mice, in which the coding region of B3gnt1 was replaced with
a lacZ cassette, were generated using C57BL/6 ES cells obtained from the
trans-NIH Knockout Mouse Project (KOMP). Genotypic procedures are
described in the supplemental experimental procedures. All animal treatments
were done in accordance with the regulations and policies of the Johns
Hopkins Animal Care and Use Committee.
Immunohistochemistry, In Situ Hybridization, and Western Blotting
Antibodies were used at the following dilutions: anti-IIH6 (1:100, Millipore), anti
b-dystroglycan (1:100, Santa Cruz), 2H3 (1:3,000, concentrated ascites,
DSHB), anti-Nestin (1:100, DSHB) anti-L1 (1:250, Millipore), anti-Laminin
(1:1000, Sigma), anti-Perlecan (1:500, Millipore), anti-Collagen IV (1:500,
Southern Biotech). In situ hybridization was performed using standard proce-
dures and the following probe for dystroglycan (nucleotodes 562–1,034 of
NM_010017). Slit1 and Slit2 probes were described previously (Yuan et al.,
1999). Analysis of dystroglycan glycosylation and laminin binding activity in
various tissues by Western blotting was performed as described (Satz et al.,
2010), and are detailed further in the supplemental experimental procedures.
DiI Injections and L1 Quantification in Spinal Cords
To label commissural axons at the floor plate, open book preparations from
E13 embryos were unilaterally injected with DiI and imaged 16–24 hr later.
The behavior of commissural axons was scored as normal, stalled, straight,
or random (axons projecting both anteriorly and posteriorly following floor
plate exit). For quantification of the ventrolateral funiculus area, the area occu-
pied by L1 positive axons in the ventral funiculus and lateral funiculus was
calculated using ImageJ using the motor exit point as the demarcation
between ventral and lateral funiculi. Three different forelimb levels sections
were quantified per animal, and at least three animals were used for each
genotype.
Slit-Dystroglycan Binding
To test binding between dystroglycan and Slit, COS7 cells were transfected
with constructs encoding a-dystroglcyan-Fc (DG-Fc), AP alone, AP-Slit2
LRR (amino acid postion 273–505 of human Slit2), AP-Slit2 Cterm (amino
acid position 1122–1529 of human Slit2), or AP-Slit2 Cterm AVA. Secreted
ligands were collected from the supernatant, concentrated, and dialyzed in
binding buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 2.5 mM MgCl2,
2.5 mM CaCl2). For DG-Fc binding experiments, DG-Fc was incubated
Neuron
Dystroglycan and Axonal Guidanceovernight with the indicated ligands, then recovered by binding to protein A/G
beads for two hours, washed five times in binding buffer, and eluted by boiling
in sample buffer. For analysis of Slit binding to endogenous dystroglycan, Slit
ligands were incubated overnight with WGA-enriched fractions isolated from
mouse brain tissue that had been dialyzed overnight in binding buffer. Ligands
contained a C-terminal 63 His tag and were recovered by a two-hour incuba-
tion with Ni-NTA beads, washed five times in binding buffer, and eluted by
boiling in sample buffer.
AP Binding Assays
For COS7 AP-binding, cells expressing either full-length dystroglycan or full-
length Robo-1 were incubated with the indicated ligands. For AP-section
binding, 50 mm cryostat sections were incubated with the indicated ligands.
The AP-Robo construct was generated by cloning amino acids 1–709 of Rat
Robo1 into the AP-Tag5 vector. Further details are provided in the supple-
mental experimental procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.neuron.2012.10.009.
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